SPN-810

Tardy marketing application filing, trial failure troubles Supernus investors
Endpoints
Wed, 11/6/19 - 10:23 am
Supernus
earnings
ADHD
SPN-812
SPN-810
clinical trials
Supernus Receives FDA Fast Track Designation for SPN-810
Marketwatch
Sat, 08/16/14 - 04:29 pm
Supernus
FDA
fast track
SPN-810
ADHD
After 2 Drug Approvals, Can Supernus Deliver In 2013?
Seeking Alpha
Mon, 11/26/12 - 10:26 am
Supernus Pharmaceuticals
SPN-810
epilepsy
Oxtellar XR
ADHD
Supernus Pharmaceuticals Raises $42 Million to Prepare for Launch of Product Candidates in Epilepsy and Develop Pipeline in ADHD
BioMedReports
Sat, 01/7/12 - 02:34 pm
Supernus Pharmaceuticals
SPN-538
SPN-810
SPN-812
ADHD
epilepsy